Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Skystar Bio-Pharmaceutical Co (NASDAQ:SKBI)

1.17
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
1.03
Today|||52-Week Range
5.92
-72.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues47.6M52.8M33.6M42.5M
 
 
 
 
 
Cost of Goods Sold20.7M24.7M13.7M19.3M
 
 
 
 
 
Depreciation And Amortization1.3M1.9M1.4M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income25.5M26.2M18.5M21.5M
 
 
 
 
 
General Expenses7.4M11.0M9.9M8.5M
 
 
 
 
 
Research And Development684.8K2.8M2.2M956.0K
 
 
 
 
 
Total Operating Expenses29.4M37.5M25.0M29.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income18.1M15.2M8.6M13.0M
 
 
 
 
 
Extraordinary Credit0.001.4M37.8K--
 
 
 
Extraordinary Charge-612.9K0.000.00-56.8K
 
 
 
Interest Expense On Debt58.8K140.9K706.8K750.4K
 
 
 
 
 
Other Expenses-49.2K43.7K498.6K48.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income17.4M16.5M8.4M12.9M
 
 
 
 
 
Income Taxes-3.3M-2.9M-2.2M-2.4M
 
 
 
 
 
Net Income14.1M13.7M6.2M10.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.1M7.2M7.5M7.7M
 
 
 
 
 
Shares To Calculate EPS Diluted7.1M7.2M7.5M7.7M
 
 
 
 
 
 
Earnings Per ShareEPS$1.98$1.90$0.83$1.38
 
 
 
 
 
EPS Diluted$1.97$1.90$0.83$1.37